FDA Investigator Raymond T Oji

Raymond T Oji has conducted inspections on 74 sites in 11 countries as of 04 May 2006. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
74
Last Inspection Date:
04 May 2006
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America, France, Switzerland, Sweden, India, Belgium, Germany, Japan, Italy, Israel, Canada
FDA Investigators that have inspected at least one site in common with Raymond T Oji:
Adam R Cooke, Alan P Kurtzberg, Alberto A Viciedo, Alice S Tsao, Alicia K Mckinsey, Alicia M Mozzachio, Alla Dubrovsky, Almaris N Alonso, Amanda L Fyles, Amir Alavi, Andrace L Deyampert, Andrea A Branche, Andrea D Swingle, Andrea George, PhD, Andrew P Lin, Andrew S Limson, Andrew W Harmon, Angel K Sandhu, Anh M Lac, Ann L Demarco, Anna Lazar, Annemarie Bodnar, Anthony F Lorenzo, Ariel Cruz Figueroa, Ashar P Parikh, Atul J Agrawal, Azza Talaat, Barbara J Wilcox, PhD, Barbara Janine Breithaupt, Barbara M Frazier, Bei Y He, Benjamin J Smith, Bichsa T Tran, Binh T Nguyen, Bonita S Chester, Bonnie E Conley, Bonnie E Pierson, Brett R Havranek, Bryan A Galvez, Burnell M Henry, Byungja E Marciante, Calvin B Koerner, Candace Y Gomez Broughton, Carl A Anderson, Carl A Huffman, III, Carl Lee, Carla A Norris, Carla J Lundi, Carole L Jones, Carolyn A Renshaw, Caryn M Everly, Caryn M Mcnab, Catherine J Laufmann, CDR Ileana Barreto Pettit, CDR Rochelle B Young, RPh, MSA, Chaoying C Ma, Charles I Ann, Charles L Larson, Charles L Zhou, Charles M Edwards, Charles R Cote, RIC, Chelsea N Sealey, Cheryl A Clausen, Chris A Sack, Christine M Parmentier, Christopher R Czajka, Christopher T Peters, Claudia Mperez Kasmarski, Comyar Shoghi, Constantin Y Philopoulos, Corrine M Carter, Dana M Klimavicz, Dandan Wang, PhD, Daniel C Geffin, Daniel J Lahar, Daniel J Roberts, Daniel R Solis, Darlene B Almogela, David A Paterson, David K Lau, David M Beltran, David Serrano, Debara R Reese, Debara Reese, Deborah M Trout, Demitria J Xiradakis, Denise L Burosh, Denise M Digiulio, Dennis Cantellops Paite, Dennis E Guilfoyle, PhD, Diana M Rand, Diane L Raccasi, Dina A Tallman, Dipesh K Shah, Donald C Obenhuber, PhD, Donna Mwilliams Hill, PhD, Douglas A Campbell, Dr. Barbara D Paul, PhD, Dr. Carmelo Rosa, Dr. Jason R Caballero, Dr. Mark J Seaton, PhD, Dr. Ralph M Bernstein, PhD, Dr. Sriram Subramaniam, PhD, Dr. Zhihao Qiu (Peter), PhD, Dr. Zhou Chen (nmi), MD PhD, Dustin P Tran, Dustin R Abaonza, Dyana K Stone, Edmund F Mrak, Jr, Edwin Martinez, Eileen A Liu, Elizabeth M Jacobson, Emal Wahab, Emest F Bizjak, Emily J Orban, Emily Shacter, Emmanuel Adu Gyamfi, PhD, Eric L Dong, BS, Eric M Mueller, PharmD, Eric S Weilage, Eric W Anderson, Erin C Hill, Evelyn Taha, Evelyn Wong, Farhana Khan, Felix Maldonado, Frederick F Razzaghi, Frederick L Fricke, Gavin T Cua, Gene R Gunn, Gerald Feldman, Gerald M Feldman, PhD, Gerald N Mcgirl, DDS, Gina M Hall, Gregory A Berg, Gregory Price, Gregson A Joseph, Gwyn G Dickinson, Henry K Lau, Hung H Do, MS, Iraida Ortiz, Israel Santiago, OCM, Italia Nappi, Jacob G Lutz, James C Lee, PharmD, James L Dunnie, Jr, James R Evans, Jamie P Webb, Jane S Wernberg, Janet D Blount, Jannifer L Degroot, Javier O Vega, Jawaid Hamid, Jean Blackston Hill, Jeanne Fringer, PhD, Jeffery A Johnson, Jeffrey A Sommers, Jeffrey D Meng, Jeffrey M Watson, Jeffrey P Raimondi, Jeffrey W Shrifter, DPM, Jennifer A Kemp, Jennifer L Johnson, Jennifer Lalama, Jennifer M Gogley, Jinnie Kokiatkulkij, Joan T Briones, Joanne Hosting, Jocelyn E Massey, Jocelyn E Sparks, Joe X Phillips, Joey V Quitania, Jogy George, John A Gonzalez, Jolanna A Norton, Jose A Lopez, Jose Acruz Gonzalez, Jose R Hernandez, Joseph A Piechocki, Joseph Kutze, PhD, Joseph P Iser, MD, Joseph R Strelnik, Joseph X Phillips, Joshua S Hunt, Joslyn K Brunelle, PhD, Juanita P Versace, Justin A Boyd, Karen D Phung, Karen E D'orazio, Karen M Montgomery (KMM), Kari M Johansen, Katherine E Jacobitz, Katherine Szestypalow, Katie L Penno, Kelvin Cheung, Kenneth M Gordon, Kent C Faul, Kevin A Gonzalez, Kevin P Foley, Kham Phommachanh, Khoa Nathanv Tran, Kim Lthomas Cruse, Kimberly L Anderson, Kristen D Evans, Kristin M Abaonza, Kula N Jha, L'oreal F Walker, Lakisha M Williams, Lance Mde Souza, MBA, Larry K Austin, Lata C Mathew, PhD, Laura Fontan, MS, Lauren Iacono Connors, PhD, Laurie A Haxel, Laurie P Norwood, Laurimer Kuilan Torres, Lawrence J Stringer, Lawton W Lum, LCDR Chad N Thompson, LCDR Debra Emerson, LCDR Jennifer H Rhyu, Leigh Anne Myers, Lequita M Mayhew, Leslie D Wagner, Lija V Fellows, Linda F Murphy, Linda Linh N Adams, Linda Thai, Linh Tu, Lisa M Bellows, Lisa Shin, Lori J Silverstein, Lorna F Jones, Louis B Cencetti, Lucila B Nwatu, Luella J Rossi, Luis A Dasta, Lydia I Rosas Marty, Lynda L Perry, PhD, Maan S Abduldayem, Mabel M Lee, Maida Henesian (NMI), Makini Cobourne Duval, PhD, Marco S Esteves, Marcus F Yambot, Margaret M Annes, Marie F Morin, Marie Falcone, Marie K Kinkade, Marie T Falcone, Mariza M Jafary, Mark A Tucker, Mark C Saale, Mark E Chan, Mark R Mcclain, Marsha W Major, Marshalette O Edwards, Martin K Yau, PhD, Mary E Storch, Mary R Hole, Matthew J Johnson, Matthew J Sienko, Matthew R Clabeaux, Megan A Haggerty, Meisha R Sampson, Meisha Waters, Melina Lrodriguez Upton, Melissa J Garcia, Mercy Oyugi, Meyer J Slobotsky, Michael A Charles, Michael A Taylor, Michael D Garcia, Michael R Goga, Michael R Klapal, Michael S Araneta, Michael Shanks, MS, Michael T Cyrus, Michele L Forster, PhD, Michele L Obert, Michele Perry Williams, Michelle Rfrazier Jessen, PhD, Mihaly S Ligmond, Min Shanmabel Liu, Mohsen Rajabi Abhari, FDA, Montgomery Montgomery, Karen M, Mra B Kamberem, Mra Davism, Mra Mcculloughj, Mra Munizn, Muna Algharibeh, Muralidhara B Gavini, PhD, Myra K Casey, Nailing Zhang, Nancy G Schmidt, Navneet Kaur, Nayan J Patel, Neali H Lucas, Nicholas L Hunt, Nicholas L Paulin, Nicholas Obiri, PhD, Nicole A Lloyd, Nicole E Knowlton, Niketa Patel, Nilufer M Tampal, PhD, Noreen Muñiz, Omotunde O Osunsanmi, Otto D Vitillo, Pal S Mayasandra, Paraluman S Leonin, Parul M Patel, Patricia A Cochran, Patricia H Dlugosz, Patrick B Cummings, Patrick C Klotzbuecher, Patsy J Domingo, Paul E Stein, Paul L Bellamy, Paul L Figarole, Jr, Paul Mouris, Paula A Trost, Paula J Bretz, Perry H Gambrell, Peter E Baker, Peter Kessler, PhD, Peter R Lenahan, Philip F Istafanos, DMV, MS, Prabhu P Raju, Qiao Y Bobo, Qin Xu, Quynh H Strandberg, Rachel C Harrington, Rafael E Arroyo, Rafeeq A Habeeb, Ralph A Erickson, Randall N Johnson, Ravi S Harapanhalli, Reba A Gates, Rebecca E Dombrowski, Rebecca Rodriguez, Rebecca T Davis, Regina T Brown, Richard E Needham, Richard L Friedman, Riley C Myers, PhD, Robert C Coleman, Robert C Steyert, Robert D Tollefsen, Robert J Doyle, Robert J Ham, Robert M Barbosa, Rochelle K Kimmel, Roger F Zabinski, Rose Ashley, Roy R Rinc, Ruben C Ayala, PharmD, Rumany C Penn, PharmD, Russell J Glapion, Russell K Riley, Saied A Asbagh, Saleem A Akhtar, Sam H Haidar, PhD, Samina S Khan, Samuel T Walker, Sandra A Boyd, Sandra A Hughes, Sandra S Saniga, Sangeeta M Khurana, PhD, Santiago Gallardo Johnson, Sarah E Mcmullen, Sarah E Rhoades, Sarah Forney, Satheesh Thomas, Scott N Lim, Sean R Marcsisin, Seema S Singh, Serge L Beaucage, Sergio Chavez (NMI), Seyyida Saterfield, Shannon B Ruelle, Sharon K Thoma, PharmD, Sheilyn H Huang, Shelley H Beausoleil, Sherri J Jackson, Shirley H Isbill, Shuang Tang, Sidney B Priesmeyer, Simone E Pitts, Sina Shojaee, Sixto M Mercado Rios, Sneha S Patel, Sonya L Karsik, RAC, Sparky L Bartee, Stephanie A Slater, MS, Stephen D Brown, Stephen R Souza, Steven C Madzo, Steven D Kehoe, Steven M Weinman, Stuart W Russell, Sudipan Karmakar, Sue Lee Chan, Susan D Yuscius, Susan F Laska, MS, Susan M Jackson, Susan P Bruederle, Suyang Qin, Taichun Qin, PhD, Tamala P Magee, Ted L Anderson, Temar Q Williams, Terri L Dodds, Thea C Grome, Thomas J Arista, Thomas R Withers, Thomas W Nojek, Thuy T Nguyen, LCDR, Timothy C Grome, Timothy T Kapsala, Tina M Pawlowski, Tod J Merkel, Todd M Bozicevich, Truong Xuan Nguyen (Andy), Uduak M Inokon, Uttaniti Limchumroon (Tom), Vilmary Negron Rodriguez, Vioela J Caze, Virgilio F Pacio, CSO, Viviana Matta, Viviana R Ramirez, Walden H Lee, Wayne E Seifert, William D Tingley, William J Leonard, William V Millar, Xiaoping Guan, Yangmin Ning, Yi Wang, PhD, Ying Xin Fan, PhD, Yiyue Zhang (nmi), PhD, Yumi J Hiramine, Yvette Mlacour Davis, Yvonne E Lozano, Zachary A Bogorad, Zachary L Stamm, Zhong Li, PhD

Raymond T Oji's Documents

Publish Date Document Type Title
June, 2004 FDA 483 Merck KGaA - Form 483, 2004-06-16
February, 2002 FDA 483 Pharmacia & Upjohn AB - Form 483, 2002-02-20
May, 2004 FDA 483 MBI Distributing, Inc - Form 483, 2004-05-04
January, 2000 FDA 483 Delpharm Boucherville Canada Inc - Form 483, 2000-01-28
September, 2003 FDA 483 Response Padagis Israel Pharmaceuticals Ltd - Form 483R, 2003-09-15
May, 2003 EIR Eli Lilly and Company - EIR, 2003-05-29
February, 2001 EIR Teva Parenteral Medicines, Inc. - EIR, 2001-02-14
November, 2000 FDA 483 SOLVIAS FRANCE - Form 483, 2000-11-03
January, 2004 FDA 483 Wockhardt Limited - Form 483, 2004-01-30
February, 2006 EIR Impax Laboratories, Inc. - EIR, 2006-02-09
February, 2002 FDA 483 Pfizer Health AB - Form 483, 2002-02-25
September, 2003 FDA 483 Padagis Israel Pharmaceuticals Ltd - Form 483, 2003-09-04
February, 2000 FDA 483 Response Neopharm Labs Inc - Form 483R, 2000-05-17
September, 2005 EIR Impax Laboratories, Inc. - EIR, 2005-09-14
November, 2002 FDA 483 Cambrex Proformaco Landen NV - Form 483, 2002-11-14
February, 2001 FDA 483 Teva Parenteral Medicines, Inc. - Form 483, 2001-02-14
October, 2000 FDA 483 Novartis Pharma S.A. - Form 483, 2000-10-26
November, 2002 FDA 483 Response Romark Belgium BV - Form 483R, 2002-12-12
July, 2001 EIR Mylan Specialty, L.P. - EIR, 2001-07-12
January, 2004 FDA 483 Response Wockhardt Limited - Form 483R, 2004-03-06
May, 2003 FDA 483 Eli Lilly and Company - Form 483, 2003-05-29
March, 2002 FDA 483 Abraxis Bioscience LLC - Form 483, 2002-03-01
February, 2001 FDA 483 Response Teva Parenteral Medicines, Inc. - Form 483R, 2001-02-21
February, 2002 FDA 483 Response Pfizer Health AB - Form 483R, 2002-03-15
January, 2000 EIR Delpharm Boucherville Canada Inc - EIR, 2000-01-28
April, 2006 EIR ALZA Corporation - EIR, 2006-04-21
August, 2003 EIR Teva Pharmaceutical Industries Ltd. - EIR, 2003-10-24
June, 2000 FDA 483 International Medication Systems, Ltd. - Form 483, 2000-06-23
February, 2000 EIR QLT Inc. - EIR, 2000-07-11
February, 2006 FDA 483 Pacific BioLabs - Form 483, 2006-02-27
January, 2005 FDA 483 AMPAC Fine Chemicals LLC - Form 483, 2005-01-12
September, 2002 EIR Alza Corporation - EIR, 2002-09-19
November, 2002 EIR Romark Belgium BV - EIR, 2003-02-07
February, 2002 EIR Pfizer Health AB - EIR, 2002-02-25
June, 2004 EIR Merck KGaA - EIR, 2004-08-11
January, 2004 EIR Wockhardt Limited - EIR, 2004-03-26
October, 2000 FDA 483 Bristol-Myers Squibb, S.p.A. - Form 483, 2000-10-20
April, 2005 FDA 483 Lobob Laboratories Inc - Form 483, 2005-04-28
January, 2000 FDA 483 Response Delpharm Boucherville Canada Inc - Form 483R, 2000-03-28
November, 2005 EIR Sanofi-Aventis Deutschland GmbH - EIR, 2005-11-04
February, 2000 FDA 483 Neopharm Labs Inc - Form 483, 2000-02-01
January, 2000 FDA 483 Genentech, Inc. - Form 483, 2000-01-14
August, 2001 FDA 483 AMPAC Fine Chemicals LLC - Form 483, 2001-08-16
September, 2003 EIR Padagis Israel Pharmaceuticals Ltd - EIR, 2003-10-24
August, 2003 FDA 483 Teva Pharmaceutical Industries Ltd. - Form 483, 2003-08-28
August, 2003 FDA 483 Response Teva Pharmaceutical Industries Ltd. - Form 483R, 2003-08-28
March, 2006 EIR Genentech, Inc. - EIR, 2006-03-09
January, 2000 EIR Genentech, Inc. - EIR, 2000-01-14
June, 2004 FDA 483 Response Merck KGaA - Form 483R, 2004-06-30
August, 2001 EIR AMPAC Fine Chemicals LLC - EIR, 2001-08-16
October, 2000 FDA 483 Confarma AG - Form 483, 2000-10-31
February, 2001 EIR Astex Pharmaceuticals, Inc - EIR, 2001-02-16
March, 2003 FDA 483 MBI Distributing, Inc - Form 483, 2003-03-14
June, 2000 EIR International Medication Systems, Ltd. - EIR, 2000-06-23
March, 2005 FDA 483 MBI Distributing, Inc - Form 483, 2005-03-08
November, 2005 FDA 483 Sanofi-Aventis Deutschland GmbH - Form 483, 2005-11-04
February, 2000 EIR Neopharm Labs Inc - EIR, 2000-05-09

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more